Global Molecular Diagnosis and Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Molecular Diagnosis and Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Molecular Diagnosis and Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diagnostic Laboratories accounting for % of the Molecular Diagnosis and Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PCR segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Molecular Diagnosis and Therapy include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, and Danaher Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Molecular Diagnosis and Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PCR
DNA Sequencing
NGS
Market segment by Application, can be divided into
Diagnostic Laboratories
Research & Academic Laboratories
Market segment by players, this report covers
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux Sa
Danaher Corporation
Diasorin
Grifols
Hologic
Illumina
Qiagen
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Molecular Diagnosis and Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Molecular Diagnosis and Therapy, with revenue, gross margin and global market share of Molecular Diagnosis and Therapy from 2019 to 2022.
Chapter 3, the Molecular Diagnosis and Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Molecular Diagnosis and Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Molecular Diagnosis and Therapy research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Molecular Diagnosis and Therapy
1.2 Classification of Molecular Diagnosis and Therapy by Type
1.2.1 Overview: Global Molecular Diagnosis and Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Type in 2021
1.2.3 PCR
1.2.4 DNA Sequencing
1.2.5 NGS
1.3 Global Molecular Diagnosis and Therapy Market by Application
1.3.1 Overview: Global Molecular Diagnosis and Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostic Laboratories
1.3.3 Research & Academic Laboratories
1.4 Global Molecular Diagnosis and Therapy Market Size & Forecast
1.5 Global Molecular Diagnosis and Therapy Market Size and Forecast by Region
1.5.1 Global Molecular Diagnosis and Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Molecular Diagnosis and Therapy Market Size by Region, (2017-2022)
1.5.3 North America Molecular Diagnosis and Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Molecular Diagnosis and Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Molecular Diagnosis and Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Molecular Diagnosis and Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Molecular Diagnosis and Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Molecular Diagnosis and Therapy Market Drivers
1.6.2 Molecular Diagnosis and Therapy Market Restraints
1.6.3 Molecular Diagnosis and Therapy Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Product and Solutions
2.1.4 Abbott Laboratories Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Molecular Diagnosis and Therapy Product and Solutions
2.2.4 Agilent Technologies Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Becton, Dickinson and Company
2.3.1 Becton, Dickinson and Company Details
2.3.2 Becton, Dickinson and Company Major Business
2.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Product and Solutions
2.3.4 Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans
2.4 Biomérieux Sa
2.4.1 Biomérieux Sa Details
2.4.2 Biomérieux Sa Major Business
2.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Product and Solutions
2.4.4 Biomérieux Sa Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Biomérieux Sa Recent Developments and Future Plans
2.5 Danaher Corporation
2.5.1 Danaher Corporation Details
2.5.2 Danaher Corporation Major Business
2.5.3 Danaher Corporation Molecular Diagnosis and Therapy Product and Solutions
2.5.4 Danaher Corporation Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Danaher Corporation Recent Developments and Future Plans
2.6 Diasorin
2.6.1 Diasorin Details
2.6.2 Diasorin Major Business
2.6.3 Diasorin Molecular Diagnosis and Therapy Product and Solutions
2.6.4 Diasorin Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Diasorin Recent Developments and Future Plans
2.7 Grifols
2.7.1 Grifols Details
2.7.2 Grifols Major Business
2.7.3 Grifols Molecular Diagnosis and Therapy Product and Solutions
2.7.4 Grifols Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Grifols Recent Developments and Future Plans
2.8 Hologic
2.8.1 Hologic Details
2.8.2 Hologic Major Business
2.8.3 Hologic Molecular Diagnosis and Therapy Product and Solutions
2.8.4 Hologic Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Hologic Recent Developments and Future Plans
2.9 Illumina
2.9.1 Illumina Details
2.9.2 Illumina Major Business
2.9.3 Illumina Molecular Diagnosis and Therapy Product and Solutions
2.9.4 Illumina Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Illumina Recent Developments and Future Plans
2.10 Qiagen
2.10.1 Qiagen Details
2.10.2 Qiagen Major Business
2.10.3 Qiagen Molecular Diagnosis and Therapy Product and Solutions
2.10.4 Qiagen Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Qiagen Recent Developments and Future Plans
2.11 Roche Diagnostics
2.11.1 Roche Diagnostics Details
2.11.2 Roche Diagnostics Major Business
2.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Product and Solutions
2.11.4 Roche Diagnostics Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Roche Diagnostics Recent Developments and Future Plans
2.12 Siemens AG
2.12.1 Siemens AG Details
2.12.2 Siemens AG Major Business
2.12.3 Siemens AG Molecular Diagnosis and Therapy Product and Solutions
2.12.4 Siemens AG Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Siemens AG Recent Developments and Future Plans
2.13 Thermo Fisher Scientific
2.13.1 Thermo Fisher Scientific Details
2.13.2 Thermo Fisher Scientific Major Business
2.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Product and Solutions
2.13.4 Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Molecular Diagnosis and Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Molecular Diagnosis and Therapy Players Market Share in 2021
3.2.2 Top 10 Molecular Diagnosis and Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Molecular Diagnosis and Therapy Players Head Office, Products and Services Provided
3.4 Molecular Diagnosis and Therapy Mergers & Acquisitions
3.5 Molecular Diagnosis and Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Molecular Diagnosis and Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Molecular Diagnosis and Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Molecular Diagnosis and Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Molecular Diagnosis and Therapy Revenue by Type (2017-2028)
6.2 North America Molecular Diagnosis and Therapy Revenue by Application (2017-2028)
6.3 North America Molecular Diagnosis and Therapy Market Size by Country
6.3.1 North America Molecular Diagnosis and Therapy Revenue by Country (2017-2028)
6.3.2 United States Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Molecular Diagnosis and Therapy Revenue by Type (2017-2028)
7.2 Europe Molecular Diagnosis and Therapy Revenue by Application (2017-2028)
7.3 Europe Molecular Diagnosis and Therapy Market Size by Country
7.3.1 Europe Molecular Diagnosis and Therapy Revenue by Country (2017-2028)
7.3.2 Germany Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
7.3.3 France Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Molecular Diagnosis and Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Molecular Diagnosis and Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region
8.3.1 Asia-Pacific Molecular Diagnosis and Therapy Revenue by Region (2017-2028)
8.3.2 China Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
8.3.5 India Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Molecular Diagnosis and Therapy Revenue by Type (2017-2028)
9.2 South America Molecular Diagnosis and Therapy Revenue by Application (2017-2028)
9.3 South America Molecular Diagnosis and Therapy Market Size by Country
9.3.1 South America Molecular Diagnosis and Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Molecular Diagnosis and Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Molecular Diagnosis and Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country
10.3.1 Middle East & Africa Molecular Diagnosis and Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Molecular Diagnosis and Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Molecular Diagnosis and Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Molecular Diagnosis and Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Molecular Diagnosis and Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Molecular Diagnosis and Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Molecular Diagnosis and Therapy Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Molecular Diagnosis and Therapy Product and Solutions
Table 9. Abbott Laboratories Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Major Business
Table 12. Agilent Technologies Molecular Diagnosis and Therapy Product and Solutions
Table 13. Agilent Technologies Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Becton, Dickinson and Company Corporate Information, Head Office, and Major Competitors
Table 15. Becton, Dickinson and Company Major Business
Table 16. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product and Solutions
Table 17. Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Biomérieux Sa Corporate Information, Head Office, and Major Competitors
Table 19. Biomérieux Sa Major Business
Table 20. Biomérieux Sa Molecular Diagnosis and Therapy Product and Solutions
Table 21. Biomérieux Sa Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Danaher Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Danaher Corporation Major Business
Table 24. Danaher Corporation Molecular Diagnosis and Therapy Product and Solutions
Table 25. Danaher Corporation Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Diasorin Corporate Information, Head Office, and Major Competitors
Table 27. Diasorin Major Business
Table 28. Diasorin Molecular Diagnosis and Therapy Product and Solutions
Table 29. Diasorin Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Grifols Corporate Information, Head Office, and Major Competitors
Table 31. Grifols Major Business
Table 32. Grifols Molecular Diagnosis and Therapy Product and Solutions
Table 33. Grifols Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Hologic Corporate Information, Head Office, and Major Competitors
Table 35. Hologic Major Business
Table 36. Hologic Molecular Diagnosis and Therapy Product and Solutions
Table 37. Hologic Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Illumina Corporate Information, Head Office, and Major Competitors
Table 39. Illumina Major Business
Table 40. Illumina Molecular Diagnosis and Therapy Product and Solutions
Table 41. Illumina Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Qiagen Corporate Information, Head Office, and Major Competitors
Table 43. Qiagen Major Business
Table 44. Qiagen Molecular Diagnosis and Therapy Product and Solutions
Table 45. Qiagen Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Roche Diagnostics Major Business
Table 48. Roche Diagnostics Molecular Diagnosis and Therapy Product and Solutions
Table 49. Roche Diagnostics Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Siemens AG Corporate Information, Head Office, and Major Competitors
Table 51. Siemens AG Major Business
Table 52. Siemens AG Molecular Diagnosis and Therapy Product and Solutions
Table 53. Siemens AG Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 55. Thermo Fisher Scientific Major Business
Table 56. Thermo Fisher Scientific Molecular Diagnosis and Therapy Product and Solutions
Table 57. Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Molecular Diagnosis and Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Molecular Diagnosis and Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Molecular Diagnosis and Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Molecular Diagnosis and Therapy Players Head Office, Products and Services Provided
Table 62. Molecular Diagnosis and Therapy Mergers & Acquisitions in the Past Five Years
Table 63. Molecular Diagnosis and Therapy New Entrants and Expansion Plans
Table 64. Global Molecular Diagnosis and Therapy Revenue (USD Million) by Type (2017-2022)
Table 65. Global Molecular Diagnosis and Therapy Revenue Share by Type (2017-2022)
Table 66. Global Molecular Diagnosis and Therapy Revenue Forecast by Type (2023-2028)
Table 67. Global Molecular Diagnosis and Therapy Revenue by Application (2017-2022)
Table 68. Global Molecular Diagnosis and Therapy Revenue Forecast by Application (2023-2028)
Table 69. North America Molecular Diagnosis and Therapy Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Molecular Diagnosis and Therapy Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Molecular Diagnosis and Therapy Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Molecular Diagnosis and Therapy Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Molecular Diagnosis and Therapy Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Molecular Diagnosis and Therapy Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Molecular Diagnosis and Therapy Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Molecular Diagnosis and Therapy Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Molecular Diagnosis and Therapy Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Molecular Diagnosis and Therapy Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Molecular Diagnosis and Therapy Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Molecular Diagnosis and Therapy Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Molecular Diagnosis and Therapy Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Molecular Diagnosis and Therapy Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Molecular Diagnosis and Therapy Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Molecular Diagnosis and Therapy Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Molecular Diagnosis and Therapy Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Molecular Diagnosis and Therapy Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Molecular Diagnosis and Therapy Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Molecular Diagnosis and Therapy Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Molecular Diagnosis and Therapy Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Molecular Diagnosis and Therapy Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Molecular Diagnosis and Therapy Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Molecular Diagnosis and Therapy Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Molecular Diagnosis and Therapy Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Molecular Diagnosis and Therapy Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Molecular Diagnosis and Therapy Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Molecular Diagnosis and Therapy Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Molecular Diagnosis and Therapy Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Molecular Diagnosis and Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Molecular Diagnosis and Therapy Picture
Figure 2. Global Molecular Diagnosis and Therapy Revenue Market Share by Type in 2021
Figure 3. PCR
Figure 4. DNA Sequencing
Figure 5. NGS
Figure 6. Molecular Diagnosis and Therapy Revenue Market Share by Application in 2021
Figure 7. Diagnostic Laboratories Picture
Figure 8. Research & Academic Laboratories Picture
Figure 9. Global Molecular Diagnosis and Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Molecular Diagnosis and Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Molecular Diagnosis and Therapy Revenue Market Share by Region (2017-2028)
Figure 12. Global Molecular Diagnosis and Therapy Revenue Market Share by Region in 2021
Figure 13. North America Molecular Diagnosis and Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Molecular Diagnosis and Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Molecular Diagnosis and Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Molecular Diagnosis and Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Molecular Diagnosis and Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Molecular Diagnosis and Therapy Market Drivers
Figure 19. Molecular Diagnosis and Therapy Market Restraints
Figure 20. Molecular Diagnosis and Therapy Market Trends
Figure 21. Abbott Laboratories Recent Developments and Future Plans
Figure 22. Agilent Technologies Recent Developments and Future Plans
Figure 23. Becton, Dickinson and Company Recent Developments and Future Plans
Figure 24. Biomérieux Sa Recent Developments and Future Plans
Figure 25. Danaher Corporation Recent Developments and Future Plans
Figure 26. Diasorin Recent Developments and Future Plans
Figure 27. Grifols Recent Developments and Future Plans
Figure 28. Hologic Recent Developments and Future Plans
Figure 29. Illumina Recent Developments and Future Plans
Figure 30. Qiagen Recent Developments and Future Plans
Figure 31. Roche Diagnostics Recent Developments and Future Plans
Figure 32. Siemens AG Recent Developments and Future Plans
Figure 33. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 34. Global Molecular Diagnosis and Therapy Revenue Share by Players in 2021
Figure 35. Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Molecular Diagnosis and Therapy Revenue Market Share in 2021
Figure 37. Global Top 10 Players Molecular Diagnosis and Therapy Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Molecular Diagnosis and Therapy Revenue Share by Type in 2021
Figure 40. Global Molecular Diagnosis and Therapy Market Share Forecast by Type (2023-2028)
Figure 41. Global Molecular Diagnosis and Therapy Revenue Share by Application in 2021
Figure 42. Global Molecular Diagnosis and Therapy Market Share Forecast by Application (2023-2028)
Figure 43. North America Molecular Diagnosis and Therapy Sales Market Share by Type (2017-2028)
Figure 44. North America Molecular Diagnosis and Therapy Sales Market Share by Application (2017-2028)
Figure 45. North America Molecular Diagnosis and Therapy Revenue Market Share by Country (2017-2028)
Figure 46. United States Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Molecular Diagnosis and Therapy Sales Market Share by Type (2017-2028)
Figure 50. Europe Molecular Diagnosis and Therapy Sales Market Share by Application (2017-2028)
Figure 51. Europe Molecular Diagnosis and Therapy Revenue Market Share by Country (2017-2028)
Figure 52. Germany Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Molecular Diagnosis and Therapy Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Molecular Diagnosis and Therapy Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Molecular Diagnosis and Therapy Revenue Market Share by Region (2017-2028)
Figure 60. China Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Molecular Diagnosis and Therapy Sales Market Share by Type (2017-2028)
Figure 67. South America Molecular Diagnosis and Therapy Sales Market Share by Application (2017-2028)
Figure 68. South America Molecular Diagnosis and Therapy Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Molecular Diagnosis and Therapy Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Molecular Diagnosis and Therapy Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Molecular Diagnosis and Therapy Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Molecular Diagnosis and Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
